South Plainfield, NJ – April 30, 2018 – Leading global genomics service provider, GENEWIZ, celebrated the grand opening of its newly expanded global headquarters on April 25 with a ribbon-cutting ceremony at its state-of-the-art office complex in South Plainfield, NJ.

Menlo Park, CA and South Plainfield, NJ – Pacific Biosciences of California, Inc. (NASDAQ: PACB), the leader in long-read, high-resolution sequencing, and GENEWIZ, a leading global genomics service provider, are pleased to announce that Professor Stephen Scherer, Ph.D., Co-founder and Director of the Centre for Applied Genomics at University of Toronto’s Hospital for Sick Children and Director of the University of Toronto McLaughlin Centre, is the winner of the 2017 Structural Variant SMRT Grant.

South Plainfield, N.J. — November 2017 — Leading global genomics service provider, GENEWIZ, was recently recognized by the New Jersey Business & Industry Association’s 2017 Awards for Excellence with the Outstanding Employer Award. This comes on the heels of being named to NJBIZ’s list of the 50 Fastest Growing Companies in New Jersey for the fifth year in the row.

Menlo Park, CA and South Plainfield, NJ – Pacific Biosciences of California, Inc. (NASDAQ: PACB), the leader in long-read sequencing, and GENEWIZ, the leading global genomics service provider, announce that Andrew Ludlow, Ph.D. from the University of Michigan, is the winner of the AACR SMRT® Grant. With this SMRT Grant, Dr. Ludlow will receive Iso-Seq® analysis on the PacBio® Sequel® System at the GENEWIZ laboratory to further his investigation to understand the splicing of transcripts regulated by NOVA1 in lung cancer cells.

South Plainfield, N.J. and Orlando, Fla. (ASHG17, Booth #323) — October 17, 2017 — Leading global genomics service provider, GENEWIZ, launches CLIA Sanger sequencing and new NGS amplicon sequencing, at booth #323 during The American Society of Human Genomics (ASHG) Annual Meeting. ASHG is the largest gathering of human genetics professionals in the world and takes place this October 17-21, 2017 in Orlando.

South Plainfield, N.J. and Washington, D.C. (AACR17, Booth #3431). — Mar 28, 2017 — Leading global genomics service provider, GENEWIZ, will launch single-cell sequencing during the American Association for Cancer Research (AACR) Annual Meeting at the Walter E. Washington Convention Center in Washington, D.C., April 1-5, 2017. Single-Cell RNA-Seq allows researchers to perform differential gene expression of thousands of cells at the individual level..

South Plainfield, NJ – November 15, 2016 – Leading global genomics service provider, GENEWIZ, was recently named to the Inc. 5000 list of fastest-growing private companies in the United States for the third consecutive year.

MOUNTAIN VIEW, Calif. — Oct 24, 2016 — Based on its recent analysis of the life science research services market, Frost & Sullivan recognizes GENEWIZ with the 2016 North America Frost & Sullivan Company of the Year Award. GENEWIZ's strategic decisions to reinvest in itself and expand its infrastructure, geographies, and customer channels have enabled it to emerge as a leader in this intensely competitive market. Its recent acquisition of Beckman Coulter Genomics (BCG) and implementation of multiple new genomics platforms demonstrate its commitment to growth and delivering cutting-edge research services using various genomics technologies and techniques.

SOUTH PLAINFIELD, NJ and SAN DIEGO – Oct. 5, 2016 – GENEWIZ, a leading global genomics services provider, today announced it will implement multiple Edico Genome DRAGEN™ Bio-IT processors to accelerate the analysis of massive volumes of genomic data generated by its high-throughput sequencing platforms. GENEWIZ’s already quick turnaround times are expected to be reduced by days for large next-generation sequencing (NGS) data sets, without sacrificing data quality or integrity.